Western blot analysis of the tumor homogenates showed that ERp46 remained overexpressed in the ERp46+-injected mice (1.6-fold; data not shown) and reduced in the shERp46-mice (21%) at sacrifice, five weeks after tumor cell injection. Here, TXNDC5 is linked to neoplasm.